Violette Shelia M. 4

What Happened

• Shelia M. Violette, Chief Scientific Officer of Q32 Bio (QTTB), reported a sale of 2,815 shares on 2026-02-25. The weighted average sale price was $4.51 per share, resulting in proceeds of approximately $12,708. This sale was to satisfy tax withholding obligations tied to the vesting of restricted stock units (RSUs), not an independent discretionary sale.

Key Details

• Transaction date: 2026-02-25; filing date (Form 4): 2026-02-27 (appears timely — within typical two-business-day reporting window).
• Transaction type: Sale (S); reason: automatic sale to cover tax withholding for RSU vesting (see footnote F1).
• Price: weighted average $4.51; individual sale prices ranged from $4.35 to $4.69 (footnote F2).
• Proceeds: ~$12,708.
• Shares after transaction: not specified in the provided data; reported holdings are held by Violette Holdings LLC. The reporting person is a manager of Violette Holdings and disclaims beneficial ownership except for any pecuniary interest (footnote F3).
• Footnotes: F1 = automatic sale for tax withholding; F2 = weighted-average price with range and offer to provide per-price details on request; F3 = shares held by Violette Holdings, with disclaimer of beneficial ownership.

Context

• This was a tax-withholding sale related to RSU vesting (routine administrative transaction). Such sales are common and do not necessarily signal the insider’s view on the company. The filing shows multiple executions at slightly different prices within the $4.35–$4.69 range, aggregated to the reported weighted average.